
DM Pharma (Global) Private Limited
About DM Pharma (Global) Private Limited
Data last updated:
DM Pharma (Global) Private Limited is a private limited company based in Chandigarh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 January 2022.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304CH2022PTC044137. Its GSTIN is 04AAJCD0060D1ZC (Chandigarh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandeep Kumar (Whole-Time Director) and Kuldeep Nautiyal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 176 Sector – 38 C, Chandigarh, India – 160036.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.75 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹36.16 Lakh (net margin 1.7%) and EBITDA of ₹56.16 Lakh (EBITDA margin 2.7%).
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.06 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.
DM Pharma (Global) Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-CH-01-0021745).
Company details
Recognitions & Rankings of DM Pharma (Global)
- Udyam number
- UDYAM-CH-01-0021745
Contact details
DM Pharma (Global) Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 176 Sector – 38 C, Chandigarh, India – 160036
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of DM Pharma (Global) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of DM Pharma (Global) is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of DM Pharma (Global) Private Limited, buy the company report.
Financials of DM Pharma (Global) Private Limited
FY 2025 filings availableDM Pharma (Global) Private Limited reported revenue of ₹20.75 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year. EBITDA rose 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹56.16 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹36.16 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.7% | |||
| Net Profit Margin | 1.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of DM Pharma (Global) Private Limited, buy the company report.
Board of directors of DM Pharma (Global) Private Limited
DM Pharma (Global) has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Rai Aggarwal | Director | 11 Jan 2022 | 4 Years 9 Months | Current |
| Sandeep Kumar | Whole-Time Director | 25 Feb 2022 | 4 Years 8 Months | Current |
| Kuldeep Nautiyal | Whole-Time Director | 30 Sep 2025 | 1 Years 0 Months | Current |
Auditor
DM Pharma (Global) Private Limited is audited by DINESH VERMANI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DINESH VERMANI | FY 2023 | 084460 |
Shareholding
The shareholding of DM Pharma (Global) Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of DM Pharma (Global) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2025 | 101075941 | Axis Bank Limited | ₹2 Cr | Open | |
| 22 Dec 2022 | 100661462 | Hdfc Bank Limited | ₹2 Cr | Open | |
| 02 Nov 2022 | 100665478 | Hdfc Bank Limited | ₹6.18 Lakh | Open |
To see the full charge records of DM Pharma (Global) Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
DM Pharma (Global) Private Limited has 2 court cases on record: 2 filed by DM Pharma (Global). All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S H.B. Traders | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of DM Pharma (Global) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for DM Pharma (Global) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
DM Pharma (Global) Private Limited has a workforce of 21 employees on its EPFO records as of Apr 06, 2024, across 2 active EPFO establishments.
GST
DM Pharma (Global) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAJCD0060D1ZC | Chandigarh | Active | 24 Aug 2022 |
To see the full GST registrations and return filing status of DM Pharma (Global) Private Limited, buy the company report.
Recent activity
DM Pharma (Global) Private Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Kuldeep Nautiyal was appointed as Whole-Time Director on 30 Sep 2025.
Frequently asked questions
DM Pharma (Global) is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 January 2022 (4+ years old) and is registered under CIN U24304CH2022PTC044137.
DM Pharma (Global) has 3 current directors:
- Sandeep Kumar - Whole-Time Director
- Kuldeep Nautiyal - Whole-Time Director
- Mahesh Rai Aggarwal - Director
The latest financial statements of DM Pharma (Global) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of DM Pharma (Global) is 04AAJCD0060D1ZC, registered in Chandigarh.
The CIN (Corporate Identification Number) of DM Pharma (Global) is U24304CH2022PTC044137. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DM Pharma (Global) has 2 court cases on record: 2 filed by the company. 2 are pending.
DM Pharma (Global) was incorporated on 11 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chandigarh.
Kuldeep Nautiyal was appointed as Whole-Time Director on 30 Sep 2025. Dinesh Kumar Aggarwal ceased to be Director on 15 Nov 2024. Sandeep Kumar was appointed as Whole-Time Director on 25 Feb 2022. DM Pharma (Global) has 5 board changes on record in total.
Yes, DM Pharma (Global) is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, DM Pharma (Global) is registered as an MSME under Udyam registration (number: UDYAM-CH-01-0021745).